ACN rated highest by Warren Buffett's Patient Investor model, passing various profitability and valuation tests.

From Nasdaq: 2024-06-09 15:05:37

Guru fundamental report for Accenture PLC (ACN) shows it rates highest using Warren Buffett’s Patient Investor model. ACN is a large-cap growth stock with a 92% rating based on profitability and valuation. The stock passes tests for earnings predictability, debt service, return on equity, total capital, free cash flow, and more. Warren Buffett is known as one of the greatest investors, consistently outperforming the S&P 500. Validea is an investment research service that follows strategies of investment legends like Buffett. For more information on Validea, click here.



Read more at Nasdaq: Guru Fundamental Report for ACN – Warren Buffett